KMT2B/MLL2 is mutated more frequently in FL as compared to DLBCL, and MLL2 protein overexpression is proposed as a prognostic marker in gastrointestinal DLBCL.[10]. The gene discussed is KMT2B; the disease is diffuse large B-cell lymphoma.